These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis. Naguib ML, Schrijver I, Gardner P, Pique LM, Doss SS, Abu Zekry MA, Aziz M, Nasr SZ. J Cyst Fibros; 2007 Apr; 6(2):111-6. PubMed ID: 16837250 [Abstract] [Full Text] [Related]
28. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing. Dhondt JL. J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772 [Abstract] [Full Text] [Related]
29. Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group. Massie J, Clements B, Australian Paediatric Respiratory Group. Pediatr Pulmonol; 2005 May; 39(5):440-6. PubMed ID: 15704202 [Abstract] [Full Text] [Related]
31. A sweat test centered protocol for the disclosure and diagnosis of cystic fibrosis in a newborn screening program. Doull IJ, Hall SJ, Bradley DM. Pediatr Pulmonol; 2007 Sep; 42(9):773-8. PubMed ID: 17659601 [Abstract] [Full Text] [Related]
39. The importance of sweat testing for older siblings of patients with cystic fibrosis identified by newborn screening. Munck A, Houssin E, Roussey M. J Pediatr; 2009 Dec; 155(6):928-930.e1. PubMed ID: 19914431 [Abstract] [Full Text] [Related]